Main

processing priority

4

site type

0 (generic, awaiting analysis)

review version

11

html import

20 (imported)

Events

first seen date

2024-02-26 05:43:53

expired found date

-

created at

2024-06-18 05:28:45

updated at

2026-02-01 05:21:46

Domain name statistics

length

10

crc

29498

tld

2211

nm parts

0

nm random digits

0

nm rare letters

0

Connections

is subdomain of id

-

previous id

0

replaced with id

0

related id

-

dns primary id

31873516

dns alternative id

368217672

lifecycle status

0 (unclassified, or currently active)

Subdomains and pages

deleted subdomains

0

page imported products

0

page imported random

0

page imported parking

0

Error counters

count skipped due to recent timeouts on the same server IP

0

count content received but rejected due to 11-799

0

count dns errors

0

count cert errors

0

count timeouts

0

count http 429

0

count http 404

0

count http 403

0

count http 5xx

0

next operation date

-

Server

server bits

server ip

-

Mainpage statistics

mp import status

20

mp rejected date

-

mp saved date

-

mp size orig

41924

mp size raw text

3003

mp inner links count

0

mp inner links status

20 (imported)

Open Graph

title

AKEEGA™ (niraparib/abiraterone acetate)

description

AKEEGA™ (niraparib/abiraterone acetate), the only treatment option combining two drugs into a once-daily treatment for adult men. See full Safety & Prescribing Info.

site name

author

updated

2025-12-28 08:46:51

raw text

AKEEGA™ (niraparib/abiraterone acetate) Patient Website For US Patients Healthcare Provider Website  Prescribing Information Patient Information Important Safety Information Medical Information Sign Up for Updates Patient Support Healthcare Provider Website  NOW APPROVED! AKEEGA™—the only FDA-approved treatment option combining two drugs into one tablet for adults with BRCA + metastatic castration-resistant prostate cancer (mCRPC) Living with advanced prostate cancer can be challenging; ask your doctor how AKEEGA™, a once-daily treatment option, may help. Patient Support & Resources Not an actual patient Janssen has built a legacy of innovation in the treatment of prostate cancer with the goal of extending life and helping patients enjoy the highest possible quality of life. Stay up-to-date About AKEEGA™ Janssen Biotech, Inc., our affiliates, and our service providers will use the information you provide to send you information about AKEEGA™ or BRCA...

Text analysis

redirect type

0 (-)

block type

0 (no issues)

detected language

1 (English)

category id

Nowotwory (78)

index version

2025123101

spam phrases

0

Text statistics

text nonlatin

0

text cyrillic

0

text characters

2389

text words

440

text unique words

226

text lines

55

text sentences

25

text paragraphs

4

text words per sentence

17

text matched phrases

3

text matched dictionaries

3

RSS

rss path

rss status

1 (priority 1 already searched, no matches found)

rss found date

-

rss size orig

0

rss items

0

rss spam phrases

0

rss detected language

0 (awaiting analysis)

inbefore feed id

-

inbefore status

0 (new)

Sitemap

sitemap status

34 (reserved: import paused pending content quality/relevance assessment after importing first 500 pages)

sitemap review version

2

sitemap urls count

10

sitemap urls adult

0

sitemap filtered products

0

sitemap filtered videos

0

sitemap found date

2024-01-25 13:55:29

sitemap process date

2025-11-17 01:09:04

sitemap first import date

-

sitemap last import date

2026-02-01 05:21:46